Kathryn A Martinez1, Yun Li2, Ken Resnicow3, John J Graff4, Ann S Hamilton5, Sarah T Hawley1,6. 1. VA Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan (KAM, STH) 2. University of Michigan School of Public Health, Department of Biostatistics, Ann Arbor, Michigan (YL) 3. University of Michigan School of Public Health, Department of Health Behavior and Health Education, Ann Arbor, Michigan (KR) 4. Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey (JJG) 5. Keck School of Medicine, University of Southern California, Los Angeles, California (ASH) 6. University of Michigan, Division of General Medicine, Ann Arbor, Michigan (STH).
Abstract
BACKGROUND: While studies suggest most women have little regret regarding their breast cancer treatment decisions immediately following treatment, no studies to date have evaluated how regret may change over time. OBJECTIVE: To measure the stability of posttreatment decision regret over time among women with breast cancer. METHODS: Women diagnosed with breast cancer between August 2005 and May 2007 reported to the Detroit, Michigan, or Los Angeles County Surveillance, Epidemiology, and End Results (SEER) registry and completed surveys at 9 months following diagnosis (time 1) and again approximately 4 years later (time 2). A decision regret scale consisting of 5 items was summed to create 2 decision regret scores at both time 1 and time 2 (range, 0-20). Multivariable linear regression was used to examine change in regret from 9 months to 4 years. Independent variables included surgery type, receipt of reconstruction, and recurrence status at follow-up. The model controlled for demographic and clinical factors. RESULTS: The analytic sample included 1536 women. Mean regret in the overall sample was 4.9 at time 1 and 5.4 at time 2 (P < 0.001). In the multivariable linear model, we found no difference in change in decision regret over time by surgery type. Reporting a new diagnosis of breast cancer at time 2 was associated with a 2.6-point increase in regret over time compared with women without an additional diagnosis (P = 0.003). Receipt of reconstruction was not associated with change in decision regret over time. CONCLUSIONS: Decision regret following treatment was low and relatively stable over time for most women. Those facing an additional diagnosis of breast cancer following treatment may be at risk for elevated regret-related distress.
BACKGROUND: While studies suggest most women have little regret regarding their breast cancer treatment decisions immediately following treatment, no studies to date have evaluated how regret may change over time. OBJECTIVE: To measure the stability of posttreatment decision regret over time among women with breast cancer. METHODS:Women diagnosed with breast cancer between August 2005 and May 2007 reported to the Detroit, Michigan, or Los Angeles County Surveillance, Epidemiology, and End Results (SEER) registry and completed surveys at 9 months following diagnosis (time 1) and again approximately 4 years later (time 2). A decision regret scale consisting of 5 items was summed to create 2 decision regret scores at both time 1 and time 2 (range, 0-20). Multivariable linear regression was used to examine change in regret from 9 months to 4 years. Independent variables included surgery type, receipt of reconstruction, and recurrence status at follow-up. The model controlled for demographic and clinical factors. RESULTS: The analytic sample included 1536 women. Mean regret in the overall sample was 4.9 at time 1 and 5.4 at time 2 (P < 0.001). In the multivariable linear model, we found no difference in change in decision regret over time by surgery type. Reporting a new diagnosis of breast cancer at time 2 was associated with a 2.6-point increase in regret over time compared with women without an additional diagnosis (P = 0.003). Receipt of reconstruction was not associated with change in decision regret over time. CONCLUSIONS: Decision regret following treatment was low and relatively stable over time for most women. Those facing an additional diagnosis of breast cancer following treatment may be at risk for elevated regret-related distress.
Authors: Victoria C Hamelinck; Esther Bastiaannet; Arwen H Pieterse; Ilse Jannink; Cornelis J H van de Velde; Gerrit-Jan Liefers; Anne M Stiggelbout Journal: Cancer Treat Rev Date: 2014-06-23 Impact factor: 12.111
Authors: Shoshana M Rosenberg; Michaela S Tracy; Meghan E Meyer; Karen Sepucha; Shari Gelber; Judi Hirshfield-Bartek; Susan Troyan; Monica Morrow; Lidia Schapira; Steven E Come; Eric P Winer; Ann H Partridge Journal: Ann Intern Med Date: 2013-09-17 Impact factor: 25.391
Authors: Sarah T Hawley; Nancy K Janz; Ann Hamilton; Jennifer J Griggs; Amy K Alderman; Mahasin Mujahid; Steven J Katz Journal: Patient Educ Couns Date: 2008-11
Authors: Abenaa M Brewster; Gabriel N Hortobagyi; Kristine R Broglio; Shu-Wan Kau; Cesar A Santa-Maria; Banu Arun; Aman U Buzdar; Daniel J Booser; Vincente Valero; Melissa Bondy; Francisco J Esteva Journal: J Natl Cancer Inst Date: 2008-08-11 Impact factor: 13.506
Authors: Ann S Hamilton; Timothy P Hofer; Sarah T Hawley; Donna Morrell; Meryl Leventhal; Dennis Deapen; Barbara Salem; Steven J Katz Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06-23 Impact factor: 4.254
Authors: Pragati G Advani; Xiudong Lei; Cameron W Swanick; Ying Xu; Yu Shen; Nathan A Goodwin; Grace L Smith; Sharon H Giordano; Kelly K Hunt; Reshma Jagsi; Benjamin D Smith Journal: Int J Radiat Oncol Biol Phys Date: 2019-02-01 Impact factor: 7.038
Authors: Ellen A Lipstein; Daniel J Lovell; Lee A Denson; Sandra C Kim; Charles Spencer; Richard F Ittenbach; Maria T Britto Journal: J Pediatr Gastroenterol Nutr Date: 2016-12 Impact factor: 2.839
Authors: Christine M Veenstra; Lauren P Wallner; Paul H Abrahamse; Nancy K Janz; Steven J Katz; Sarah T Hawley Journal: Cancer Date: 2019-01-11 Impact factor: 6.921
Authors: Lauren P Wallner; David Reyes-Gastelum; Ann S Hamilton; Kevin C Ward; Sarah T Hawley; Megan R Haymart Journal: J Clin Oncol Date: 2019-07-08 Impact factor: 50.717
Authors: Markus W Haun; Alexander Schakowski; Ariane Preibsch; Hans-Christoph Friederich; Mechthild Hartmann Journal: Health Expect Date: 2019-07-31 Impact factor: 3.377
Authors: Lauren P Wallner; Mousumi Banerjee; David Reyes-Gastelum; Ann S Hamilton; Kevin C Ward; Carrie Lubitz; Sarah T Hawley; Megan R Haymart Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958
Authors: Kerry Ettridge; Joanna Caruso; David Roder; Ivanka Prichard; Katrine Scharling-Gamba; Kathleen Wright; Caroline Miller Journal: Qual Life Res Date: 2020-09-29 Impact factor: 3.440
Authors: Maria K Venetis; Erina L MacGeorge; Dadrie F Baptiste; Ashton Mouton; Lorin B Friley; Rebekah Pastor; Kristen Hatten; Janaka Lagoo; Monet W Bowling; Susan E Clare Journal: Am J Clin Oncol Date: 2018-06 Impact factor: 2.339